Jeff Lagasse
While it hasn't yet been tested in humans, its ability to target multiple coronaviruses shows early promise.
Many have but back on healthcare visits or are planning to do so, and a substantial number are considering curbing medication spending.
Hydroxychloroquine can reduce inflammation, pain and swelling, but mild to moderate COVID patients showed more adverse events when treated with it.
The stimulus and emergency response funding will blunt some of the losses, but hospitals won't be fully compensated, Moody's found.
Reimbursement levels will go back to pre-coronavirus levels when the pandemic ends, but Congress may be pressured to make lasting change.
Potential benefits to robust analytics and real-time reporting capabilities include more reimbursement dollars and better patient care.
In addition to an expanded ED, the hospital knew it had to improve interstaff communications to bolster patient care.
The action is meant to enable GE to overcome supply chain disruptions as it addresses the surge in demand for critical equipment.
Some stroke patients may fear contracting the coronavirus, while others who are isolated may not be discovered quickly enough.
The treatment may reduce the risk to healthcare workers because it reduces the duration and quantity of viral shedding.